DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q3 2015 holdings

$2.59 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 134 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 40.0% .

 Value Shares↓ Weighting
HZNP SellHORIZON PHARMA PLC$160,173,000
-62.4%
8,081,407
-34.1%
6.20%
-56.3%
 ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0$99,819,000
-3.6%
100,750,0000.0%3.86%
+11.9%
NXTM BuyNXSTAGE MEDICAL INC$99,636,000
+20.8%
6,318,050
+9.4%
3.85%
+40.3%
GSK BuyGLAXOSMITHKLINE PLCsponsored adr$87,771,000
+53.1%
2,282,722
+65.8%
3.40%
+77.7%
AET BuyAETNA INC NEW$69,589,000
+47.7%
636,039
+72.0%
2.69%
+71.5%
FLML  FLAMEL TECHNOLOGIES SAsponsored adr$66,428,000
-23.0%
4,072,8090.0%2.57%
-10.6%
DYAX BuyDYAX CORP$54,555,000
-17.1%
2,857,773
+15.1%
2.11%
-3.7%
VNDA  VANDA PHARMACEUTICALS INC$53,965,000
-11.1%
4,784,1570.0%2.09%
+3.2%
DVA BuyDAVITA HEALTHCARE PARTNERS I$51,788,000
+2.5%
716,000
+12.6%
2.00%
+18.9%
MYL BuyMYLAN N V$51,332,000
-13.2%
1,275,000
+46.4%
1.99%
+0.9%
NVLS  NIVALIS THERAPEUTICS INC$48,409,000
-14.4%
3,732,4120.0%1.87%
-0.6%
BuyHEALTHWAYS INCnote 1.500% 7/0$47,869,000
+84.6%
51,925,000
+86.0%
1.85%
+114.4%
ARRY BuyARRAY BIOPHARMA INC$44,366,000
-35.4%
9,729,361
+2.1%
1.72%
-25.0%
ADPTQ BuyADEPTUS HEALTH INCcl a$44,041,000
+27.4%
545,328
+49.8%
1.70%
+47.9%
 ARRAY BIOPHARMA INCnote 3.000% 6/0$43,864,000
-23.0%
45,000,0000.0%1.70%
-10.5%
EHTH  EHEALTH INC$41,819,000
+0.9%
3,264,5880.0%1.62%
+17.2%
BLUE BuyBLUEBIRD BIO INC$41,321,000
-24.9%
483,000
+47.8%
1.60%
-12.8%
WBA SellWALGREENS BOOTS ALLIANCE INC$38,513,000
-29.7%
463,457
-28.5%
1.49%
-18.3%
BuyHEARTWARE INTL INCnote 3.500%12/1$37,712,000
+13.5%
39,226,000
+25.5%
1.46%
+31.8%
GBT NewGLOBAL BLOOD THERAPEUTICS IN$37,549,000890,620
+100.0%
1.45%
CRL SellCHARLES RIV LABS INTL INC$36,917,000
-14.2%
581,188
-4.9%
1.43%
-0.3%
 ENDOLOGIX INCnote 2.250%12/1$36,877,000
-7.3%
40,941,0000.0%1.43%
+7.7%
GWPH BuyGW PHARMACEUTICALS PLCads$35,737,000
-19.6%
391,122
+8.1%
1.38%
-6.7%
AACH BuyAAC HLDGS INC$35,631,000
+169.9%
1,601,376
+428.5%
1.38%
+213.2%
TEVA SellTEVA PHARMACEUTICAL INDS LTDadr$34,723,000
-9.1%
615,000
-4.8%
1.34%
+5.6%
MCK BuyMCKESSON CORP$34,350,000
+12.4%
185,646
+36.5%
1.33%
+30.4%
UAM BuyUNIVERSAL AMERN CORP NEW$33,727,000
-24.4%
4,930,787
+11.8%
1.30%
-12.2%
INFI BuyINFINITY PHARMACEUTICALS INC$33,046,000
+22.4%
3,910,721
+58.6%
1.28%
+42.2%
TEVA NewTEVA PHARMACEUTICAL INDS LTDcall$31,053,000550,000
+100.0%
1.20%
BuyACCURAY INCnote 3.750% 8/0$30,841,000
+25.5%
30,511,000
+26.6%
1.19%
+45.8%
BuySPECTRANETICS CORPmtnf 2.625% 6/0$30,252,000
-20.4%
39,831,000
+7.9%
1.17%
-7.6%
RGNX NewREGENXBIO INC$29,444,0001,336,542
+100.0%
1.14%
PCRX BuyPACIRA PHARMACEUTICALS INC$28,872,000
+92.6%
702,485
+231.4%
1.12%
+123.8%
ELGX SellENDOLOGIX INC$28,776,000
-23.4%
2,347,113
-4.2%
1.11%
-11.1%
DNAI NewPRONAI THERAPEUTICS INC$27,669,0001,348,401
+100.0%
1.07%
AKTX NewAKARI THERAPEUTICS PLCsponsored adr$27,611,0001,150,700
+100.0%
1.07%
KMPH BuyKEMPHARM INC$27,529,000
+38.2%
1,420,497
+31.0%
1.06%
+60.4%
SAGE BuySAGE THERAPEUTICS INC$27,468,000
+23.4%
649,064
+112.8%
1.06%
+43.3%
HWAY  HEALTHWAYS INC$27,411,000
-7.2%
2,465,0420.0%1.06%
+7.7%
ATRS SellANTARES PHARMA INC$26,267,000
-31.3%
15,451,124
-16.0%
1.02%
-20.3%
RAD BuyRITE AID CORP$25,632,000
+62.4%
4,222,800
+123.4%
0.99%
+88.6%
 FLUIDIGM CORP DELnote 2.750% 2/0$25,235,000
-18.5%
35,000,0000.0%0.98%
-5.3%
 WEBMD HEALTH CORPnote 1.500%12/0$23,640,000
-4.0%
23,000,0000.0%0.91%
+11.3%
GHDX SellGENOMIC HEALTH INC$23,139,000
-29.6%
1,093,516
-7.6%
0.90%
-18.3%
XNCR BuyXENCOR INC$21,855,000
-29.5%
1,787,000
+26.6%
0.84%
-18.2%
IMPR BuyIMPRIVATA INC$20,456,000
+30.5%
1,151,140
+20.1%
0.79%
+51.5%
GI  ENDOCHOICE HLDGS INC$20,422,000
-30.5%
1,797,7090.0%0.79%
-19.3%
RLYP BuyRELYPSA INC$20,380,000
+173.7%
1,101,000
+389.3%
0.79%
+217.7%
MNKKQ NewMALLINCKRODT PUB LTD CO$20,329,000317,931
+100.0%
0.79%
ANTM  ANTHEM INC$19,713,000
-14.7%
140,8060.0%0.76%
-0.9%
LOXO SellLOXO ONCOLOGY INC$19,022,000
-27.2%
1,088,225
-25.0%
0.74%
-15.5%
GLPG SellGALAPAGOS NVspon adr$17,957,000
-45.7%
441,085
-31.4%
0.70%
-36.9%
ZFGN SellZAFGEN INC$17,683,000
-49.3%
553,472
-45.1%
0.68%
-41.1%
PRTO  PROTEON THERAPEUTICS INC$17,601,000
-22.1%
1,265,3430.0%0.68%
-9.6%
DBVT BuyDBV TECHNOLOGIES S Asponsored adr$16,438,000
+244.4%
461,869
+188.2%
0.64%
+300.0%
ELOS BuySYNERON MEDICAL LTD$14,865,000
-29.1%
2,079,013
+5.3%
0.58%
-17.6%
AERI SellAERIE PHARMACEUTICALS INC$14,332,000
-63.3%
807,875
-63.5%
0.55%
-57.4%
NSTG SellNANOSTRING TECHNOLOGIES INC$14,090,000
-25.9%
880,622
-28.6%
0.54%
-13.9%
PTLA  PORTOLA PHARMACEUTICALS INC$14,058,000
-6.4%
329,8370.0%0.54%
+8.6%
AXGN SellAXOGEN INC$13,932,000
+19.1%
3,381,439
-9.3%
0.54%
+38.2%
EW SellEDWARDS LIFESCIENCES CORP$13,807,000
-54.2%
97,119
-54.2%
0.53%
-46.9%
ZLTQ SellZELTIQ AESTHETICS INC$13,455,000
-55.1%
420,063
-58.7%
0.52%
-47.9%
BKD NewBROOKDALE SR LIVING INC$12,789,000557,000
+100.0%
0.50%
NUVA SellNUVASIVE INC$12,791,000
-40.0%
265,272
-41.1%
0.50%
-30.4%
OFIX SellORTHOFIX INTL N V$12,165,000
-19.8%
360,459
-21.2%
0.47%
-6.7%
XNPT NewXENOPORT INC$11,955,0003,445,374
+100.0%
0.46%
MGNX NewMACROGENICS INC$11,931,000557,000
+100.0%
0.46%
TRUP SellTRUPANION INC$11,921,000
-15.7%
1,578,925
-7.9%
0.46%
-2.1%
NewESSA PHARMA INC$11,580,0001,859,282
+100.0%
0.45%
ACHN NewACHILLION PHARMACEUTICALS IN$11,519,0001,667,000
+100.0%
0.45%
ALIM  ALIMERA SCIENCES INC$9,769,000
-52.1%
4,420,5800.0%0.38%
-44.3%
NEOS NewNEOS THERAPEUTICS INC$9,630,000458,332
+100.0%
0.37%
GENN SellGENESIS HEALTHCARE INC$9,429,000
-32.6%
1,538,232
-27.4%
0.36%
-21.7%
ARNA SellARENA PHARMACEUTICALS INC$8,864,000
-72.6%
4,640,877
-33.5%
0.34%
-68.2%
PACB BuyPACIFIC BIOSCIENCES CALIF IN$8,000,000
-6.5%
2,185,771
+47.1%
0.31%
+8.4%
NVAX NewNOVAVAX INC$7,353,0001,040,000
+100.0%
0.28%
HTWR NewHEARTWARE INTL INC$7,020,000134,200
+100.0%
0.27%
OXFD SellOXFORD IMMUNOTEC GLOBAL PLC$7,016,000
-9.7%
519,670
-7.4%
0.27%
+4.6%
TNXP  TONIX PHARMACEUTICALS HLDG C$6,959,000
-41.0%
1,315,5510.0%0.27%
-31.6%
FOMX  FOAMIX PHARMACEUTICALS LTD$6,956,000
-28.5%
948,9340.0%0.27%
-17.0%
EGLTQ NewEGALET CORP$6,288,000477,123
+100.0%
0.24%
AXGT NewAXOVANT SCIENCES LTD$6,262,000484,664
+100.0%
0.24%
ADHD SellALCOBRA LTD$6,024,000
-15.4%
997,349
-8.4%
0.23%
-1.7%
RIGL  RIGEL PHARMACEUTICALS INC$5,923,000
-23.0%
2,397,8550.0%0.23%
-10.5%
ALQA SellALLIQUA BIOMEDICAL INC$5,318,000
-39.9%
1,677,546
-0.1%
0.21%
-30.2%
STRM BuySTREAMLINE HEALTH SOLUTIONS$5,205,000
+2.0%
2,272,759
+24.7%
0.20%
+18.2%
CATB SellCATABASIS PHARMACEUTICALS IN$5,084,000
-43.6%
628,482
-14.8%
0.20%
-34.3%
NewJAZZ INVESTMENTS I LTDnote 1.875% 8/1$5,098,0005,000,000
+100.0%
0.20%
SCYX  SCYNEXIS INC$5,043,000
-17.2%
692,7810.0%0.20%
-3.9%
TCON  TRACON PHARMACEUTICALS INC$4,738,000
-13.8%
485,0000.0%0.18%0.0%
LIFE  ATYR PHARMA INC$4,735,000
-44.6%
461,5300.0%0.18%
-35.8%
DSCI BuyDERMA SCIENCES INC$4,720,000
-32.0%
1,002,201
+3.4%
0.18%
-20.8%
STDY BuySTEADYMED LTD$4,669,000
-30.8%
1,315,169
+3.8%
0.18%
-19.6%
AKRXQ SellAKORN INC$4,580,000
-69.6%
160,667
-53.4%
0.18%
-64.7%
ALDX  ALDEYRA THERAPEUTICS INC$4,026,000
-24.9%
690,5380.0%0.16%
-12.8%
CASM  CAS MED SYS INC$4,000,000
-2.3%
3,200,0000.0%0.16%
+14.0%
PEN NewPENUMBRA INC$4,010,000100,000
+100.0%
0.16%
BDSI NewBIODELIVERY SCIENCES INTL IN$3,892,000700,000
+100.0%
0.15%
MRTX SellMIRATI THERAPEUTICS INC$3,788,000
-69.7%
110,049
-72.3%
0.15%
-64.7%
PSDV BuyPSIVIDA CORP$3,548,000
+814.4%
972,110
+845.4%
0.14%
+953.8%
GNCA SellGENOCEA BIOSCIENCES INC$3,434,000
-55.7%
501,257
-11.2%
0.13%
-48.4%
VSAR NewVERSARTIS INC$3,194,000277,000
+100.0%
0.12%
PRQR  PROQR THRAPEUTICS N V$3,051,000
-12.6%
209,3980.0%0.12%
+1.7%
CDTX  CIDARA THERAPEUTICS INC$3,022,000
-9.3%
237,5830.0%0.12%
+5.4%
BITI  BIOTIE THERAPIES OYJsponsored adr$2,874,000
-34.5%
219,5580.0%0.11%
-24.0%
TRIB SellTRINITY BIOTECH PLCspon adr new$2,814,000
-40.6%
246,000
-6.3%
0.11%
-31.0%
IVTY SellINVUITY INC$2,819,000
-8.7%
201,068
-8.0%
0.11%
+5.8%
BEAT SellBIOTELEMETRY INC$2,720,000
-55.2%
222,215
-65.5%
0.10%
-48.0%
DSCO BuyDISCOVERY LABORATORIES INC N$2,561,000
+2.9%
8,537,995
+133.3%
0.10%
+19.3%
MZOR SellMAZOR ROBOTICS LTDsponsored ads$2,525,000
-27.3%
228,909
-12.3%
0.10%
-15.5%
ACUR NewACURA PHARMACEUTICALS INC$2,410,0001,025,641
+100.0%
0.09%
 TRILLIUM THERAPEUTICS INC$2,245,000
-40.3%
172,3070.0%0.09%
-30.4%
VRTX NewVERTEX PHARMACEUTICALS INC$1,927,00018,500
+100.0%
0.08%
ILMN NewILLUMINA INC$1,934,00011,000
+100.0%
0.08%
LJPC NewLA JOLLA PHARMACEUTICAL CO$1,806,00065,000
+100.0%
0.07%
VCYT  VERACYTE INC$1,797,000
-57.9%
383,2560.0%0.07%
-50.7%
ATEC  ALPHATEC HOLDINGS INC$1,644,000
-76.1%
4,982,7380.0%0.06%
-72.1%
PTN  PALATIN TECHNOLOGIES INC$1,620,000
-9.0%
2,000,0000.0%0.06%
+6.8%
BIIB NewBIOGEN INC$1,605,0005,500
+100.0%
0.06%
KIN  KINDRED BIOSCIENCES INC$1,452,000
-23.7%
279,2040.0%0.06%
-11.1%
BVX  BOVIE MEDICAL CORP$1,342,000
-30.1%
688,2290.0%0.05%
-18.8%
NVTA  INVITAE CORP$1,203,000
-51.5%
166,6660.0%0.05%
-43.4%
KND BuyKINDRED HEALTHCARE INC$1,136,000
-20.2%
72,100
+2.8%
0.04%
-6.4%
THC NewTENET HEALTHCARE CORP$1,019,00027,602
+100.0%
0.04%
CDNA  CAREDX INC$955,000
-35.9%
229,0000.0%0.04%
-26.0%
 CORSICANTO LTDnote 3.500% 1/1$917,000
-15.4%
1,000,0000.0%0.04%
-2.8%
ESPR BuyESPERION THERAPEUTICS INC NE$778,000
-54.5%
32,970
+57.8%
0.03%
-47.4%
HALO NewHALOZYME THERAPEUTICS INC$676,00050,349
+100.0%
0.03%
CAH NewCARDINAL HEALTH INC$615,0008,000
+100.0%
0.02%
SEM NewSELECT MED HLDGS CORP$593,00055,000
+100.0%
0.02%
OPHT NewOPHTHOTECH CORP$405,00010,000
+100.0%
0.02%
VRX NewVALEANT PHARMACEUTICALS INTL$281,0001,575
+100.0%
0.01%
POZN  POZEN INC$260,000
-43.5%
44,5830.0%0.01%
-33.3%
TRXC SellTRANSENTERIX INC$140,000
-84.2%
61,819
-79.0%
0.01%
-82.8%
ASND ExitASCENDIS PHARMA A Ssponsored adr$0-20,859
-100.0%
-0.01%
RCPT ExitRECEPTOS INC$0-2,000
-100.0%
-0.01%
PRGO ExitPERRIGO CO PLC$0-3,500
-100.0%
-0.02%
IRWD ExitIRONWOOD PHARMACEUTICALS INC$0-63,700
-100.0%
-0.03%
IART ExitINTEGRA LIFESCIENCES HLDGS C$0-59,468
-100.0%
-0.13%
ZSPH ExitZS PHARMA INC$0-132,000
-100.0%
-0.23%
STJ ExitST JUDE MED INC$0-107,719
-100.0%
-0.26%
AMPH ExitAMPHASTAR PHARMACEUTICALS IN$0-448,532
-100.0%
-0.26%
DERM ExitDERMIRA INC$0-496,387
-100.0%
-0.29%
JUNO ExitJUNO THERAPEUTICS INC$0-183,149
-100.0%
-0.32%
IMMU ExitIMMUNOMEDICS INC$0-2,505,872
-100.0%
-0.34%
HUM ExitHUMANA INC$0-75,500
-100.0%
-0.48%
EXEL ExitEXELIXIS INCput$0-4,000,000
-100.0%
-0.50%
INSM ExitINSMED INC$0-891,546
-100.0%
-0.72%
BSX ExitBOSTON SCIENTIFIC CORP$0-1,405,348
-100.0%
-0.83%
INGN ExitINOGEN INC$0-601,772
-100.0%
-0.89%
ONCE ExitSPARK THERAPEUTICS INC$0-631,192
-100.0%
-1.27%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AERIE PHARMACEUTICALS INC36Q3 20223.6%
CENTENE CORP DEL30Q3 20233.0%
BIOCRYST PHARMACEUTICALS INC29Q3 20232.2%
MOLINA HEALTHCARE INC26Q3 20221.7%
EHEALTH INC25Q3 20202.0%
INTERCEPT PHARMACEUTICALS IN24Q1 20232.2%
MYLAN NV23Q3 20206.2%
PORTOLA PHARMACEUTICALS INC23Q1 20196.0%
BROOKDALE SR LIVING INC23Q3 20232.2%
ALIMERA SCIENCES INC23Q3 20190.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
DA32 Life Science Tech Acquisition Corp.August 01, 20235,145,00091.1%
CareMax, Inc.March 13, 202318,691,42316.4%
CareMax, Inc.June 02, 202218,691,42320.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings
TypeFiled
32024-03-19
42024-03-19
42024-03-12
32024-03-08
42024-02-16
13F-HR2024-02-14
42024-02-08
32024-02-01
42023-11-21
13F-HR2023-11-14

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (2585129000.0 != 2585133000.0)

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings